Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.3 - $2.15 $46,580 - $77,036
35,831 Added 35.61%
136,456 $237,000
Q3 2023

Nov 14, 2023

SELL
$2.31 - $4.18 $82,374 - $149,058
-35,660 Reduced 26.17%
100,625 $232,000
Q2 2023

Aug 14, 2023

BUY
$4.26 - $6.92 $580,574 - $943,092
136,285 New
136,285 $580,000
Q2 2021

Aug 16, 2021

SELL
$4.72 - $7.15 $223,737 - $338,924
-47,402 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.13 - $7.24 $10,834 - $15,290
2,112 Added 4.66%
47,402 $260,000
Q4 2020

Feb 16, 2021

BUY
$5.18 - $6.03 $13,561 - $15,786
2,618 Added 6.14%
45,290 $238,000
Q3 2020

Nov 16, 2020

SELL
$4.86 - $7.07 $90,133 - $131,120
-18,546 Reduced 30.3%
42,672 $222,000
Q2 2020

Aug 14, 2020

BUY
$6.44 - $9.45 $394,243 - $578,510
61,218 New
61,218 $444,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $12.6M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.